Diabetes drug may fight inflammation after stent procedure
Disease control
Recruiting now
This study tests whether empagliflozin, a diabetes drug, can reduce inflammation after a heart stent procedure. 100 patients with stable coronary artery disease will take either empagliflozin or a placebo for three days before their scheduled stent placement. Researchers will mea…
Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC